Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...
B
Pharmaceutical is Zen Rated B and is the 46th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.24B$30.56-3.11%$123.68M38.68x3.95
United States
CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$52.36M$3.502.94%$3.27M-14.00x1.45
United States
AMRX
AMNEAL PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.59B$8.27-1.78%$503.18M-206.75x-26.56
INDV
INDIVIOR PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.92B$15.38-1.54%$78.00M256.33x-5.83
United Kingdom
KMDA
KAMADA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$434.74M$7.56-2.83%$32.38M27.00x0.49
Israel
ANIP
ANI PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.39B$64.00-1.83%$68.47M-50.79x2.03
United States
PCRX
PACIRA BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.05B$22.73-2.49%$31.32M-10.10x0.99
United States
COLL
COLLEGIUM PHARMACEUTICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.03B$32.00-2.53%$311.83M23.53x5.96
United States
AVDL
AVADEL PHARMACEUTICALS PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.00B$10.383.39%-$13.23M-38.44x1.27
Ireland
HCM
HUTCHMED (CHINA) LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.89B$16.562.03%$47.79M82.80x0.66
Hong Kong
PRGO
PERRIGO CO PLC
NYSE
Drug Manufacturers - Specialty & Generic
$3.72B$27.05-1.31%$518.70M-20.65x1.24
Ireland
EBS
EMERGENT BIOSOLUTIONS INC
NYSE
Drug Manufacturers - Specialty & Generic
$376.15M$6.93-5.07%$105.40M-2.73x1.58
United States
SUPN
SUPERNUS PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.88B$33.51-1.33%$171.84M29.65x0.31
United States
PBH
PRESTIGE CONSUMER HEALTHCARE INC
NYSE
Drug Manufacturers - Specialty & Generic
$3.71B$75.15-1.66%$369.24M17.40x0.85
United States
ETON
ETON PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$386.98M$14.43-0.76%-$273.00k-75.95x2.44
United States
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$18.40B$16.04-2.31%$1.50B-14.07x5.13
Israel
AYTU
AYTU BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.39M$2.170.93%$16.13M10.85x2.56
United States
ELAN
ELANCO ANIMAL HEALTH INC
NYSE
Drug Manufacturers - Specialty & Generic
$7.26B$14.61-1.88%$1.40B19.22x1.04
United States
BGM
BGM GROUP LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$64.32M$8.9010.15%-$186.07k-44.50x0.21
China
DERM
JOURNEY MEDICAL CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$162.60M$6.98-5.80%-$1.43M-17.90x2.94
United States
ZTS
ZOETIS INC
NYSE
Drug Manufacturers - Specialty & Generic
$68.05B$152.86-1.79%$3.90B27.39x2.03
United States
ALVO
ALVOTECH
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.54B$8.41-5.51%$288.04M20.51x-5.12
Luxembourg
BHC
BAUSCH HEALTH COMPANIES INC
NYSE
Drug Manufacturers - Specialty & Generic
$2.37B$6.421.26%$2.85B-58.36x-22.54
Canada
HLN
HALEON PLC
NYSE
Drug Manufacturers - Specialty & Generic
$44.19B$9.73-1.72%$3.12B23.73x1.12
United Kingdom
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$10.48B$8.93-2.30%-$530.80M-2.82x1.46
United States
ALKS
ALKERMES PLC
NASDAQ
Drug Manufacturers - Specialty & Generic
$4.76B$28.85-2.83%$463.88M13.42x0.38
Ireland
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$12.99B$131.24-2.88%$494.70M43.31x0.45
United States
TKNO
ALPHA TEKNOVA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$235.14M$4.40-2.00%-$15.95M-9.36x0.45
United States
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$478.66M$6.70-2.33%$62.82M9.85x0.14
United States
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$5.62B$81.26-2.17%$438.66M22.14x0.77
United States
IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$111.17M$0.69-6.91%$60.23M-3.44x-1.98
United States
QNTM
QUANTUM BIOPHARMA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$52.35M$19.31-8.14%-$14.60M-1.74x1.80
Canada
UPC
UNIVERSE PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.10M$3.72-2.87%$1.81M0.00x0.46
China
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.25B$10.44-2.79%-$40.59M-21.31x0.78
United States
CRON
CRONOS GROUP INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$778.55M$2.02-2.42%$9.12M14.43x0.04
Canada
AMPH
AMPHASTAR PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$998.41M$21.18-3.51%$265.38M7.25x1.17
United States
RDY
DR REDDYS LABORATORIES LTD
NYSE
Drug Manufacturers - Specialty & Generic
$12.12B$14.53-0.21%$1.12B18.42x0.47
India
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$511.22M$4.03-10.24%$1.30M-23.71x0.41
United States
OGI
ORGANIGRAM GLOBAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$191.39M$1.43-3.38%$22.38M32.50x0.38
Canada
EOLS
EVOLUS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$597.69M$9.27-2.52%-$30.78M-10.53x-33.31
United States
TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE
Drug Manufacturers - Specialty & Generic
$46.42B$14.75-1.93%$7.92B62.50x1.05
Japan
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.77B$13.70-6.68%-$3.56M-1,522.22x0.03
Hong Kong
RMTI
ROCKWELL MEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$37.25M$1.09-1.80%$4.97M-54.50x0.71
United States
HROW
HARROW INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.26B$34.37-3.51%$18.65M-56.34x5.46
United States
EVO
EVOTEC SE
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.49B$4.201.94%N/AN/A1.13
Germany
SBFM
SUNSHINE BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.87M$1.511.21%-$5.07M-0.30x0.29
United States
KALA
KALA BIO INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$35.33M$5.48-3.95%-$29.63M-0.69x7.45
United States
ACB
AURORA CANNABIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$252.49M$4.49-1.97%$26.15M154.83x0.43
Canada
SXTC
CHINA SXT PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.52M$1.670.48%$6.42M0.01x1.06
China
ASRT
ASSERTIO HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$63.22M$0.66-3.79%$2.00M-2.06x1.64
United States
BIOA
BIOAGE LABS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$162.04M$4.52-2.38%N/AN/A0.10
United States
LFCR
LIFECORE BIOMEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$284.72M$7.69-5.88%-$14.23M-5.20x85.36
United States
CRDL
CARDIOL THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$106.57M$1.29-3.01%-$25.32M-3.84x0.45
Canada
ESPR
ESPERION THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$223.97M$1.13-4.24%-$88.48M-1.41x-1.76
United States
CGC
CANOPY GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$201.86M$1.09-6.84%-$391.33M-0.27x0.88
Canada
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.07M$4.7019.29%-$9.74M-0.07x0.62
United States
TLRY
TILRAY BRANDS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$596.85M$0.59-9.74%-$806.71M-0.56x0.26
Canada
AQST
AQUESTIVE THERAPEUTICS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$399.30M$4.02-0.25%-$36.71M-6.81x-2.68
United States
IMCC
IM CANNABIS CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$9.60M$3.11-6.61%$769.29kN/A7.84
Canada
APUS
APIMEDS PHARMACEUTICALS US INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$20.49M$1.77-3.80%N/AN/A-1.15
United States
BFRI
BIOFRONTERA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.75M$0.82-4.65%-$9.71M-0.62x34.37
United States
CTOR
CITIUS ONCOLOGY INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$110.19M$1.54-20.62%-$25.16M-4.16x1.57
United States
AKAN
AKANDA CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.64M$1.29-3.01%-$3.59M-0.33x0.85
United Kingdom
TLPH
TALPHERA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$9.02M$0.44-6.38%-$11.64M-0.98x1.68
United States
TXMD
THERAPEUTICSMD INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$13.14M$1.14-2.99%-$1.69M-6.31x0.43
United States
PRFX
PAINREFORM LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.19M$1.496.43%-$14.66M-0.05x1.48
Israel
RDHL
REDHILL BIOPHARMA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$0.00$1.91-12.25%-$13.99MN/A-4.85
Israel
IXHL
INCANNEX HEALTHCARE INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$10.01M$0.3444.07%-$21.16M-0.28x1.19
Australia
GELS
GELTEQ LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$16.33M$1.73-1.70%N/AN/A0.34
Australia
INCR
INTERCURE LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$70.60M$1.50-3.42%-$9.16M-3.66x0.92
Israel
SCYX
SCYNEXIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$29.66M$0.76-7.20%-$26.67M-1.36x0.34
United States
SNOA
SONOMA PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$6.05M$3.680.00%-$2.77M-1.32x2.10
United States
YCBD
CBDMD INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$8.61M$0.970.73%$1.41M-0.22x15.43
United States
FLGC
FLORA GROWTH CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$15.12M$0.67-2.76%-$12.47M-0.68x3.71
United States
DRRX
DURECT CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$16.45M$0.53-5.36%-$5.34M-3.53x1.68
United States
CPHI
CHINA PHARMA HOLDINGS INC
NYSEMKT
Drug Manufacturers - Specialty & Generic
$5.55M$1.70-10.05%-$2.21M-0.79x1.04
China
EVOK
EVOKE PHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.66M$5.13-10.55%-$4.55M-2.35x1.80
United States

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the #1 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 18 points higher than the pharmaceutical industry average of 27.

PAHC passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 73.64% over the past year, overperforming other pharmaceutical stocks by 142 percentage points.

Phibro Animal Health has an average 1 year price target of $27.67, a downside of -9.47% from Phibro Animal Health's current stock price of $30.56.

Phibro Animal Health stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Phibro Animal Health, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)


Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #2 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 30, which is 3 points higher than the pharmaceutical industry average of 27.

CPIX passed 9 out of 33 due diligence checks and has average fundamentals. Cumberland Pharmaceuticals has seen its stock return 139.73% over the past year, overperforming other pharmaceutical stocks by 208 percentage points.

3. Amneal Pharmaceuticals (NASDAQ:AMRX)


Amneal Pharmaceuticals (NASDAQ:AMRX) is the #3 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 25, which is -2 points lower than the pharmaceutical industry average of 27. Although this number is below the industry average, our proven quant model rates AMRX as a "A".

AMRX passed 8 out of 33 due diligence checks and has weak fundamentals. Amneal Pharmaceuticals has seen its stock return 12.06% over the past year, overperforming other pharmaceutical stocks by 80 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $11.50, an upside of 39.06% from Amneal Pharmaceuticals's current stock price of $8.27.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 7 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 4.03%, which is 2 percentage points higher than the pharmaceutical industry average of 1.81%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -15.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Perrigo Co (NYSE:PRGO)


Perrigo Co (NYSE:PRGO) has an annual dividend yield of 3.11%, which is 1 percentage points higher than the pharmaceutical industry average of 1.81%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -85.6% indicates that its dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.65%, which is 1 percentage points higher than the pharmaceutical industry average of 1.81%.

Kamada's dividend payout ratio of 71.4% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -2.27% in the last day, and down -1.16% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 0, which is -19 points higher than the pharmaceutical industry average of 19. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -89.4% in the past year. It has underperformed other stocks in the pharmaceutical industry by -21 percentage points.

2. Bausch Health Companies (NYSE:BHC)


Bausch Health Companies (NYSE:BHC) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 0, which is -19 points higher than the pharmaceutical industry average of 19. It passed 0 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates BHC a Valuation Rating of "A".

Bausch Health Companies's stock has dropped -12.3% in the past year. It has overperformed other stocks in the pharmaceutical industry by 56 percentage points.

3. Amphastar Pharmaceuticals (NASDAQ:AMPH)


Amphastar Pharmaceuticals (NASDAQ:AMPH) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Amphastar Pharmaceuticals has a valuation score of 71, which is 52 points higher than the pharmaceutical industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Amphastar Pharmaceuticals's stock has dropped -45.36% in the past year. It has overperformed other stocks in the pharmaceutical industry by 23 percentage points.

Are pharmaceutical stocks a good buy now?

46.15% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 43.21% over the next year.

8.62% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 22.41% of pharmaceutical stocks are rated B (Buy), 50% are rated C (Hold), 13.79% are rated D (Sell), and 5.17% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -13.2x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.